Curt Scribner
Independent Regulatory Consultant
Medical and Regulatory Affairs
Aequus BioPharma
United States of America
Biography
Scribner has more than 25 years of drug development and regulatory affairs experience. He is currently an independent regulatory consultant specializing in biotechnology. He was recently Senior Vice President of Medical and Regulatory Affairs at RRD International, LLC. He joined RRD from Intarcia Therapeutics, where he was the Vice President of Regulatory and Quality Affairs and Chief Regulatory Officer. Previously, Dr. Scribner was Chief Regulatory Consultant for Quintiles Consulting, where he developed and wrote numerous regulatory applications for the FDA and European regulatory agency, EMA. Prior to Quintiles Consulting, Dr. Scribner spent 10 years at FDA, where he held a variety of positions and was involved in reviewing products regulated by the Center for Biologics. Dr. Scribner holds an MD from the University of Colorado College of Medicine, and completed a rheumatology fellowship at National Institute of Health. He holds an MBA from the University of Maryland College of Business and Management, and a BA in biology from Grinnell College.
Research Interest
Medical and Regulatory Affairs